uPA and PAI-1: Clinically and technically validated prognostic markers in breast cancer

被引：0
|
作者：
Duffy, M. J. [1 ]
机构：
[1] St Vincents Univ Hosp, Dublin, Ireland
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 06期
关键词：
D O I：
10.1016/j.ejcsup.2006.04.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S11
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [41] uPA/PAI-1 expression and uPA promoter methylation in meningiomas
    Kandenwein, Julia Annabel
    Park-Simon, Tjoung-Won
    Schramm, Johannes
    Simon, Matthias
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 533 - 539
  • [42] Comparative analysis of uPA/PAI-1 in core biopsies versus surgical breast cancer samples
    Vetter, M.
    Lantzsch, T.
    Abraha-Spath, R. S.
    Olenik, C.
    Thomssen, C.
    Danner, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S66 - S67
  • [43] uPA/PAI-1 as a predictive Factor in HR+ and HER2 Breast Cancer
    Wieder, V
    Kaufhold, S.
    Kantelhardt, J. E.
    Thomssen, C.
    Vetter, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : E25 - E25
  • [44] Prognostic factors upa and PAI-1: Feasibility and validity of determination in clinical routine
    Vetter, M.
    Lantzsch, T.
    Abraha-Spaeth, S.
    Bauerfeind, U.
    Geurts-Moespot, A.
    Grosse, R.
    Dittmer, J.
    Sweep, F.
    Schmitt, M.
    Harbeck, N.
    Thomssen, C.
    BREAST, 2009, 18 : S35 - S35
  • [45] Molecular types and prognostic markers uPA/PAI-1 for 2,497 early breast cancer patients in the multicenter, randomized NNBC 3-Europe trial
    Kantelhardt, E. J.
    Thomssen, C.
    Vetter, M.
    Meisner, C.
    Schmidt, M.
    Martin, P.
    Sweep, F.
    Von Minckwitz, G.
    Schmitt, M.
    Harbeck, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
    Lampelj, Maja
    Arko, Darja
    Cas-Sikosek, Nina
    Kavalar, Rajko
    Ravnik, Maja
    Jezersek-Novakovic, Barbara
    Dobnik, Sarah
    Dovnik, Nina Fokter
    Takac, Iztok
    RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 357 - 364
  • [47] Limited prognostic value of c-erbB-2 compared to uPA and PAI-1 in primary breast carcinoma
    Bouchet, C
    Ferrero-Poüs, M
    Hacène, K
    Becette, V
    Spyratos, F
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (03): : 207 - 217
  • [48] K167 expression and uPA/PAI-1 level: adjuvant chemotherapy markers in intermediate risk early breast cancer.
    Deluche, Elise
    Venat-Bouvet, Laurence
    Leobon, Sophie
    Fermeaux, Veronique
    Aubard, Yves
    Saidi, Nadira
    Jammet, Isabelle
    Tubiana-Mathieu, Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Abnormal expression of uPA and PAI-1 in lymphangioleiomyomatosis
    Zhe, X
    Schuger, L
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 424A - 424A
  • [50] Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    Ravnik, M.
    Takac, I.
    Arko, D.
    Goricek, B.
    Sikocek, N. Cas
    Lampelj, M.
    Ravnik, J.
    Cufer, T.
    EJC SUPPLEMENTS, 2008, 6 (07): : 185 - 186
12345